Antibiotic Collateral-sensitivity
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (31 December 2020) | Viewed by 401
Special Issue Editor
Special Issue Information
Dear Colleagues,
Antibiotic collateral sensitivity (CS), when acquisition of resistance to one antibiotic leads to reduced resistance to a different antibiotic, is of importance to both clinicians, potentially impacting treatment strategies for chronic infections, and researchers who want to understand the mechanism and evolution of antibiotic resistance. The CS phenomenon has been observed in a growing number of bacteria taxa, with collateral sensitivity networks documented for multiple antibiotics.
Manuscripts about collateral sensitivity have been published in a wide range of journals. The field is at a place that warrants a special edition on CS. Such an edition would benefit those interested in CS as well as allow those tangential to the field to become familiar with CS.
We are asking if you would be interested in providing a manuscript for this Special Edition. The research focus can include CS mechanisms, clinical applications that exploit CS, evolutionary implications (such as fitness costs associated with CS), or a review article that would summarize the field to date.
Dr. Todd Robert Steck
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Antibiotic collateral sensitivity
- antibiotic cross resistance
- antibiotic resistance mechanisms
- evolution of antibiotic collateral sensitivity
- in vivo collateral sensitivity
- collateral sensitivity networks
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
